The 5th International Meeting on Laminopathies, being held in Paris from 21 to 23 May, brings together international experts in nuclear envelope proteins and associated diseases, including muscular dystrophies, cardiomyopathies, accelerated ageing syndromes such as Hutchinson-Gilford progeria and metabolic disorders.
This meeting, which gathers together cardiologists, neurologists, endocrinologists, paediatricians, geneticists, researchers and patients, aims to promote international collaboration in order to increase scientific knowledge and improve the diagnosis, prevention and management of these diseases.
Oral communications and sessions chaired by researchers from the Institute of Myology
▻ Wednesday 21 May
▻ Thursday 22 May
- Session Pathogenesis of laminopathies (1) – Chairman: Antoine Muchir (team 9, MCR)
- Session Pathogenesis of laminopathies (2) – Chairman: Anne Bertrand(team 1, MCR)
- Session Clinical phenotypes – Chairman: Gisèle Bonne (team 1, MCR)
- Communication Persistent unmet needs in the prevention of sudden death in Laminopathies – Karim Wahbi (team Registries and Databases)
- Communication OPALE, Obervatory of PAtients with Laminopathies & Emerinopathies: a patient registry for disease natural history and deciphering of Genotype-phenotype relations – Gisèle Bonne (team 1, MCR)
- Session Pathogenesis of laminopathies (3) – Chairman: Bruno Cadot (team 9, MCR)
- Communication Targeting extracellular matrix to treat LMNA cardiomyopathy – Marie Kervella (team 9, MCR)
Posters
- Cardiac metabolic alteration in LMNA cardiomyopathy – Le Goff W, Le Dour C, Monaco G, Forand A, Peccate C, Landstrom AP, Muchir A
- Simtuzumab attenuates Loxl2-mediated extracellular matrix remodeling and improves cardiac function in LMNA mutation induced-dilated cardiomyopathy – Kervella M, Peccate C, Guesmia Z, Grandi F, Mougenot N, Forand A, Charrabi A, Andriantitohaina R, Meli AC, Muchir A
Download the programme
